SCHEMBL29642891

SCHEMBL29642891

CCN(CC)C(=O)c1cc2c([N+](=O)[O-])c(O)c(O)cc2cc1C(=O)N(CC)CCCCCCN

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 7/20 0.79
▸ HPGD P15428 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP2C9 P11712 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ FTO Q9C0B1 3/20 0.32
▸ MC4R P32245 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ABCC3 O15438 1/20 0.32
▸ ABCC4 O15439 1/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ GPR35 Q9HC97 1/20 0.32
▸ HSP90AA1 P07900 2/20 0.32
▸ HSP90AB1 P08238 2/20 0.32
▸ MC5R P33032 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18987105 1.00 COMT (0.79) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL18987018 0.90 COMT (0.69) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL29642820 0.90 COMT (0.69) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL31514945 0.89 COMT (1.00) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL18987117 0.89 COMT (1.00) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL18986811 0.87 COMT (0.72) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL31514942 0.86 COMT (0.76) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL18987016 0.86 COMT (0.76) COMTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL31514938 0.84 COMT (0.55) COMTHPGDCYP1A2FTOMC4R
SCHEMBL29642900 0.84 COMT (0.70) COMTHPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390351-B1 NOVEL BICYCLIC-COMPOUNDS FOR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATMENT OF PARKINSON'S DISEASE KOESTER HUBERT (DE) 2025-02-26 — — EP claimed
CN-108698984-B Bicyclic compounds for use as medicaments, in particular for the treatment of parkinson's disease H·科斯特 2022-05-10 — — CN disclosed
Send feedback